Immune responses to Helicobacter pylori infection in Bangladeshi children during their first two years of life and the association between maternal antibodies and onset of infection

Journal of Infectious Diseases

Volumn 202, Issue 11, 2010, Pages 1676-1684

  Bhuiyan, Taufiqur Rahman ^a,b   Saha, Amit ^a   Lundgren, Anna ^b   Qadri, Firdausi ^a   Svennerholm, Ann Mari ^b  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MATERNAL ANTIBODY;

ANTIBODY RESPONSE; ARTICLE; BANGLADESH; BREAST MILK; CHILD; CLINICAL ARTICLE; FECES ANALYSIS; HELICOBACTER INFECTION; HUMAN; IMMUNE RESPONSE; INFANT; ONSET AGE; PRESCHOOL CHILD; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROLOGY;

ANTIBODIES, BACTERIAL; BANGLADESH; FECES; FETAL BLOOD; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MILK, HUMAN; MOTHERS;

EID: 78649571909     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/657085     Document Type: Article

References (45)

1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1:1311-5.
2. Ernst PB, Gold BD. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol 2000; 54:615-40.
3. 13C]urea breath test and Helicobacter pylori stool antigen test for diagnosis of H. pylori infection in children from a developing country. J Clin Microbiol 2003; 41:3334-5.
4. Shaikh S, Khaled MA, Islam A, Kurpad AV, Mahalanabis D. Evaluation of stool antigen test for Helicobacter pylori infection in asymptomatic children from a developing country using 13C-urea breath test as a standard. J Pediatr Gastroenterol Nutr 2005; 40:552-4.
5. Daugule I, Rowland M. Helicobacter pylori infection in children. Helicobacter 2008; 13:41-6.
6. Bhuiyan TR, Qadri F, Saha A, Svennerholm AM. Infection by Helicobacter pylori in Bangladeshi children from birth to two years: relation to blood group, nutritional status, and seasonality. Pediatr Infect Dis J 2009; 28:79-85.
7. Rollan A, Giancaspero R, Fuster F, et al. The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country. Am J Gastroenterol 2000; 95:50-6.
8. Sarker SA, Rahman MM, Mahalanabis D, et al. Prevalence of Helicobacter pylori infection in infants and family contacts in a poor Bangladesh community. Dig Dis Sci 1995; 40:2669-72.
9. Qadri F, Saha A, Ahmed T, Al Tarique A, Begum YA, Svennerholm AM. Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh. Infect Immun 2007; 75:3961-8.
10. Okimoto T, Murakami K, Sato R, et al. Is the recurrence of Helicobacter pylori infection after eradication therapy resultant from recrudescence or reinfection, in Japan. Helicobacter 2003; 8:186-91.
11. van der Hulst RW, Rauws EA, Koycu B, et al. Helicobacter pylori reinfection is virtually absent after successful eradication. J Infect Dis 1997; 176:196-200.
12. Berstad A, Hatlebakk JG, Wilhelmsen I, et al. Follow-up on 242 patients with peptic ulcer disease one year after eradication of Helicobacter pylori infection. Hepatogastroenterology 1995; 42:655-9.
13. Hildebrand P, Bardhan P, Rossi L, et al. Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults. Gastroenterology 2001; 121:792-8.
14. Ahmad MM, Ahmed DS, Rowshon AH, et al. Long-term re-infection rate after Helicobacter pylori eradication in Bangladeshi adults. Digestion 2007; 75:173-6.
15. Mattsson A, Tinnert A, Hamlet A, Lönroth H, Bölin I, Svennerholm AM. Specific antibodies in sera and gastric aspirates of symptomatic and asymptomatic Helicobacter pylori-infected subjects. Clin Diagn Lab Immunol 1998; 5:288-93.
16. De Giacomo C, Lisato L, Negrini R, Licardi G, Maggiore G. Serum immune response to Helicobacter pylori in children: epidemiologic and clinical applications. J Pediatr 1991; 119:205-10.
17. Veenendaal RA, Peña AS, Meijer JL, et al. Long term serological surveillance after treatment of Helicobacter pylori infection. Gut 1991; 32:1291-4.
18. Engstrand L, Gustavsson S, Schwan A, Scheynius A. Local and systemic immune response in Helicobacter pylori-associated chronic gastritis before and after treatment. Scand J Gastroenterol 1993; 28:1105-11.
19. Yuceyar H, Saruc M, Kokuludag A, Terzioglu E, Goksel G, Isisag A. The systemic cellular immune response in the Helicobacter pylori-associated duodenal ulcer and chronic antral gastritis. Hepatogastroenterology 2002; 49:1177-9.
20. Bogstedt AK, Nava S, Wadstrom T, Hammarstrom L. Helicobacter pylori infections in IgA deficiency: lack of role for the secretory immune system. Clin Exp Immunol 1996; 105:202-4.
21. Gisbert JP, Trapero M, Pajares JM. Evaluation of 3 different tests for the detection of stool antigens to confirm Helicobacter pylori eradication after treatment: a pilot study. Gastroenterol Hepatol 2005; 28:615-8.
22. Bhuiyan TR, Qadri F, Bardhan PK, et al. Comparison of mucosal B-and T-cell responses in Helicobacter pylori-infected subjects in a developing and a developed country. FEMS Immunol Med Microbiol 2008; 54:70-9.
23. high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect Immun 2003; 71:1755-62.
24. Ahren C, Jertborn M, Svennerholm AM. Intestinal immune responses to an inactivated oral enterotoxigenic Escherichia coli vaccine and associated immunoglobulin A responses in blood. Infect Immun 1998; 66:3311-6.
25. Wennerås C, Qadri F, Bardhan PK, Sack RB, Svennerholm AM. Intestinal immune responses in patients infected with enterotoxigenic Escherichia coli and in vaccinees. Infect Immun 1999; 67:6234-41.
26. Chak E, Rutherford GW, Steinmaus C. The role of breast-feeding in the prevention of Helicobacter pylori infection: a systematic review. Clin Infect Dis 2009; 48:430-7.
27. Lindholm C, Quiding-Jarbrink M, Lonroth H, Hamlet A, Svennerholm AM. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 1998; 66:5964-71.
28. Mattsson A, Quiding-Järbrink M, Lönroth H, Hamlet A, Ahlstedt I, Svennerholm A. Antibody-secreting cells in the stomachs of symptomatic and asymptomatic Helicobacter pylori-infected subjects. Infect Immun 1998; 66:2705-12.
29. Hamlet AK, Erlandsson KI, Olbe L, Svennerholm AM, Backman VE, Pettersson AB. A simple, rapid, and highly reliable capsule-based 14C urea breath test for diagnosis of Helicobacter pylori infection. Scand J Gastroenterol 1995; 30:1058-63.
30. Maruyama K, Hida M, Kohgo T, Fukunaga Y. Changes in salivary and fecal secretory IgA in infants under different feeding regimens. Pediatr Int 2009; 51:342-5.
31. Kitagawa M, Natori M, Katoh M, et al. Maternal transmission of Helicobacter pylori in the perinatal period. J Obstet Gynaecol Res 2001; 27:225-30.
32. Bunn JE, Thomas JE, Harding M, Coward WA, Weaver LT. Placental acquisition of maternal specific IgG and Helicobacter pylori colonization in infancy. Helicobacter 2003; 8:568-72.
33. Weyermann M, Borowski C, Bode G, et al. Helicobacter pylori-specific immune response in maternal serum, cord blood, and human milk among mothers with and without current Helicobacter pylori infection. Pediatr Res 2005; 58:897-902. (Pubitemid 41511061)
34. Jayashree S, Bhan MK, Kumar R, Bhandari N, Sazawal S. Protection against neonatal rotavirus infection by breast milk antibodies and trypsin inhibitors. J Med Virol 1988; 26:333-8.
35. Thomas JE, Bunn JE, Kleanthous H, et al. Specific immunoglobulin A antibodies in maternal milk and delayed Helicobacter pylori colonization in Gambian infants. Clin Infect Dis 2004; 39:1155-60.
36. Glass RI, Svennerholm AM, Stoll BJ, et al. Protection against cholera in breast-fed children by antibodies in breast milk. N Engl J Med 1983; 308:1389-92.
37. Akhiani AA, Pappo J, Kabok Z, et al. Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells. J Immunol 2002; 169:6977-84.
38. Lundgren A, Trollmo C, Edebo A, Svennerholm AM, Lundin BS. Helicobacter pylori-specific CD4+ T cells home to and accumulate in the human Helicobacter pylori-infected gastric mucosa. Infect Immun 2005; 73:5612-9.
39. Nurgalieva ZZ, Conner ME, Opekun AR, et al. B-cell and T-cell immune responses to experimental Helicobacter pylori infection in humans. Infect Immun 2005; 73:2999-3006.
40. Velin D, Favre L, Bernasconi E, et al. Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model. Gastroenterology 2009; 136:2237-46.e1.
41. Nystrom J, Raghavan S, Svennerholm AM. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice. Microbes Infect 2006; 8:442-9.
42. Nyström J, Svennerholm AM. Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses. Vaccine 2007; 25:2591-8.
43. O'Keeffe J, Moran AP. Conventional, regulatory, and unconventional T cells in the immunologic response to Helicobacter pylori. Helicobacter 2008; 13:1-19.
44. Casswall TH, Sarker SA, Albert MJ, et al. Treatment of Helicobacter pylori infection in infants in rural Bangladesh with oral immunoglobulins from hyperimmune bovine colostrum. Aliment Pharmacol Ther 1998; 12:563-8.
45. Svennerholm AM, Lundgren A. Progress in vaccine development against Helicobacter pylori. FEMS Immunol Med Microbiol 2007; 50:146-56.